These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24565095)

  • 1. Use of sugammadex in Strumpell-Lorrain disease: a report of two cases.
    Franco-Hernández JA; Muñoz Rodríguez L; Ortiz de Landázuri PJ; García Hernández A
    Braz J Anesthesiol; 2013 Jan; 63(1):113-5. PubMed ID: 24565095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of sugammadex in Strumpell-Lorrain disease: a report of two cases.
    Franco-Hernández JA; Rodríguez LM; Ortiz de Landázuri PJ; Hernández AG
    Braz J Anesthesiol; 2013; 63(1):113-5. PubMed ID: 23438806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of sugammadex for reversal of neuromuscular blockade in 2 patients requiring intraoperative neurophysiological monitoring.
    Reid S; Shields MO; Luney SR
    J Neurosurg Anesthesiol; 2011 Jan; 23(1):56-7. PubMed ID: 21248496
    [No Abstract]   [Full Text] [Related]  

  • 4. Sugammadex in anesthesia practice.
    Duvaldestin P; Plaud B
    Expert Opin Pharmacother; 2010 Nov; 11(16):2759-71. PubMed ID: 20977408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of profound neuromuscular blockade with sugammadex after failure of rapid sequence endotracheal intubation: a case report.
    Barbosa FT; da Cunha RM
    Rev Bras Anestesiol; 2012; 62(2):281-4. PubMed ID: 22440384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sugammadex and profound rocuronium neuromuscular blockade induced by magnesium sulphate].
    Grandjean B; Guerci P; F Vial ; Raft J; Fuchs-Buder T; Bouaziz H
    Ann Fr Anesth Reanim; 2013 May; 32(5):378-9. PubMed ID: 23664923
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
    White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
    Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sugammadex reversal of neuromuscular blockade for thymectomy in a patient with myasthenia gravis].
    Monsalve Naharro JA; Gerónimo Pardo M; Ortiz Sánchez VE; Pérez Valdivieso JM
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):624-5. PubMed ID: 22263413
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversal of rocuronium-induced neuromuscular block with sugammadex in heart failure patients: a prospective observational study.
    Cammu G; Coart D; De Graeve K; Beelen R
    Acta Anaesthesiol Belg; 2012; 63(2):69-73. PubMed ID: 23136807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anesthesia for laparoscopic surgery in a patient with myotonic dystrophy (Steinert's disease): beneficial use of sugammadex, but incorrect use of pethidine: a case report.
    Mavridou P; Dimitriou V; Margaritis A; Manataki A
    Acta Anaesthesiol Belg; 2011; 62(2):101-4. PubMed ID: 21919378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience on the use of sugammadex in a French university hospital].
    Beny K; Mirabaud AF; Piriou V; Aulagner G; Armoiry X
    Ann Fr Anesth Reanim; 2012 Jun; 31(6):568-9. PubMed ID: 22543096
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sugammadex used in a patient with hereditary spastic paraplegia].
    Ortega U; Renedo P; Figueroa G; Aguirre J
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):619-20. PubMed ID: 22263409
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients.
    McDonagh DL; Benedict PE; Kovac AL; Drover DR; Brister NW; Morte JB; Monk TG
    Anesthesiology; 2011 Feb; 114(2):318-29. PubMed ID: 21239968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
    Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
    Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of prolonged rocuronium neuromuscular blockade with sugammadex in an obstetric patient with transverse myelitis.
    Weekes G; Hayes N; Bowen M
    Int J Obstet Anesth; 2010 Jul; 19(3):333-6. PubMed ID: 20627694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of neuromuscular block with a selective relaxant-binding agent: sugammadex.
    Ren WH; Jahr JS
    Am J Ther; 2009; 16(4):295-9. PubMed ID: 19535969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy.
    de Boer HD; van Esmond J; Booij LH; Driessen JJ
    Paediatr Anaesth; 2009 Dec; 19(12):1226-8. PubMed ID: 19863737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.